GLP-1 Special Populations
Explore peptide research and guides on glp-1 special populations.
GLP-1 Special Populations
GLP-1 Agonists After Bariatric Surgery
Between 16-37% of bariatric patients regain weight. GLP-1 drugs like semaglutide can recover two-thirds of that regain. Here is what the evidence shows.
GLP-1 Special PopulationsGLP-1 Agonists in Older Adults After 65
GLP-1 drugs reduce cardiovascular events in older adults but accelerate muscle and bone loss. Here is what the age-specific evidence shows.
GLP-1 Special PopulationsGLP-1 Drugs for Teens: The Evidence So Far
Semaglutide and liraglutide are FDA-approved for adolescent obesity. One Phase 3 trial, emerging safety data, and open questions. Evidence from 10 studies.